Jeff Geschwind, MD is a key Medical Advisor for HistoSonics. He provides strategic guidance on the development of their revolutionary non-invasive sonic beam therapy, aiming to transform the standard of care for liver cancer patients without making a single incision. https://about.me/jeff.geschwind